Mindset Pharma (MSSTF) Stock Price, News & Analysis

Company Overview

Mindset Pharma Inc. is a Canadian biotechnology company focused on the discovery and development of next-generation psychedelic medicines. The company’s research has centered on novel compounds designed to interact with serotonin receptors, particularly 5-HT2A receptors associated with the effects of psychedelic substances.

Mindset has developed proprietary drug candidates and intellectual property involving new chemical entities based on psychedelic compounds, including psilocybin-related molecules. Its work has included preclinical research intended to identify compounds with potentially improved pharmaceutical characteristics, such as more predictable dosing, differentiated duration of action, or other therapeutic advantages.

Based in Toronto, Ontario, Mindset has historically worked with academic and research partners to advance its discovery programs toward pharmaceutical development. The company’s activities have primarily been research and development oriented, with its programs requiring further laboratory, preclinical, and clinical evaluation before any potential medical use or commercialization.

Key Stats

• Today's Range: $0.54 to $0.54
• 50-Day Range: $0.54 to $0.54
• 52-Week Range: $0.16 to $0.56
• Volume: N/A
• Average Volume: 33,313 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Current Symbol: OTCMKTS:MSSTF
• CIK: N/A
• Web: www.mindsetpharma.com
• Phone: N/A
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A